The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, India reports fresh cases, with Kerala on alert.

The United States has identified multiple cases of a new COVID-19 variant, NB.1.8.1, which has been associated with the recent spike in infections across China. According to a report in the CBS, the variant was detected through the CDC's airport screening program in international travelers arriving at airports in California,

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

The travelers with cases linked to the NB.1.8.1 variant have been arriving at airports in California, Washington state, Virginia and the New York City area, according to the CDC's

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and winter — even as a new Trump administration policy has thrown into question who may be eligible for shots.

Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all Americans over 6 months of age.